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Objective: A rapid, simple and sensitive RP-HPLC method was developed and validated for the determination of bisoprolol fumarate in bulk and 
pharmaceutical dosage form.  
ABSTRACT 
Methods: Chromatographic separation was achieved within 2.5 min on ACQUITY Arc System, Waters Symmetry C18 column (3.9 mm i.d. X 150 mm, 
5 μm particle sizes) using a mobile phase consisted of acetonitrile: phosphate buffer (25:75 v/v) in an isocratic mode at a flow rate of 1.4 ml/min. 
The pH of the mobile phase was adjusted to 7.0 with orthophosphoric acid and UV detection was set at 226 nm.  
Results: The retention time for bisoprolol fumarate was found to be 2.09 min. The proposed method was validated according to ICH guidelines with 
respect to linearity, specificity precision, accuracy and robustness. The limit of detection and limit of quantification are calculated and found to be 
0.4825 and 1.4621 μg/ml; respectively.  
Conclusion: The proposed method can help research studies, quality control and routine analysis with lesser resources available. The results of the assay of 
pharmaceutical formulation of the developed method are highly reliable and reproducible and is in good agreement with the label claim of the medicines.  
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Nowadays in the pharmaceutical analysis is dominated by physico-
chemical methods of analysis, the most reliable of which are 
methods of chromatographic analysis. Chromatographic methods 
allow to carry out qualitative and quantitative determination of AFI. 
Bisoprolol is a synthetic, beta1-selective (cardioselective) 
adrenoceptor blocking agent without significant membrane stabilizing 
activity or intrinsic sympathomimetic activity in its therapeutic dosage 
range. The chemical name of bisoprolol fumarate is 1-(propan-2-
ylamino)-3-[4-(2-propan-2-yloxyethoxymethyl) phenoxy] propan-2-ol 
(fig. 1). The two substituents present in the para position of the 
benzene ring might be the reason for its β1-adrenergic receptor 
selectivity. The most prominent effect of bisoprolol fumarate is the 
negative chronotropic effect, resulting in a reduction in resting and 
exercise heart rate. There is a fall in resting and exercise cardiac 
output with little observed change in stroke volume, and only a 
small increase in right atrial pressure, or pulmonary capillary wedge 
pressure at rest or during exercise [1]. 
 
 
Fig. 1: Chemical structure of bisoprolol fumarate 
 
A literature survey was conducted and several methods were 
reported for the determination of bisoprolol fumarate, such as 
spectrophotоmetry [2-5] and liquid chromatоgraphy [6-12]. 
However, no rapid and sensitive HPLC for the determination of 
bisoprolol in its tablet dosage form.  
This novel proposed method contributes quick estimation, correct 
peak shape, precise, simple, and quick, use of smaller sample 
volumes and acetonitrile and phosphate buffer solution pH 7.0 as a 
mobile phase which is economical when compared with other 
existing methods [13]. 
The present work aimed to develop a simple, rapid, sensitive and 
specific method for the determination of bisoprolol fumarate in its 
tablet dosage form according to ICH guidelines Q2 (R1) [14].  
MATERIALS AND METHODS 
Chemicals and reagents 
Bisoprolol fumarate was obtained as a gift from Farmak 
pharmaceuticals (Kiev, Ukraine). HPLC grade acetonitrile, 
triethylamine, ammonium phosphate, orthophosphoric acid were 
obtained from Merck pharamaceticals. 
Instrumentation and chromatographic conditions 
ACQUITY Arc System, Waters Symmetry C18 column (3.9 mm i.d. X 
150 mm, 5 μm). Chromatographic separation was carriеd out at 
ambient temperature (22 °C-25 °C). The compound was separated 
isocratically with a mobile phasе consisting of acetonitrile and 
phosphate buffer solution pH 7.0 (25/75, v/v) at a flow rate 1.4 
ml/min with injection volume 10 μL. The effluent was monitorеd 
spectrophotometrically at wavelength 226 nm.  
Preparation of mobile phase 
To prepare phosphate buffer solution pH 7.0.: 6.60g of ammonium 
phosphate dissolve in 980 ml of water, add 2.0 ml of triethylamine, 
fix the pH of the solution to the value (7.0±0.05) with phosphoric 
acid, and then add the volume of the solution with water P to 1000.0 
ml and mix. 
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Stock standard solutions 
Primary stock solutions of bisoprolol fumarate was prepared daily 
separately by dissolving 25 mg of each in 250 ml volumetric flasks (0.1 
mg/ml) in mobile phase. Limits of the range of application of the 
procedure were determined from 70% to 130% to the nominal 
concentration of bisoprolol fumarate (0.1 mg/ml) in the test solution. 
Procedures  
The standard solutions were prepared by dilution of the stock 
standard solution with mobile phase. Triplicate 20.0 μL injections 
were made for each concentration and chromatographed under the 
condition described above. The peak area of each concentration was 
plotted against the corresponding concentration to obtain the 
calibration graph and regression equation was computed. 
Analysis of dosage form 
Accurately weighed twenty bisoprolol tablets and average weight 
was calculated. Accurately weighed a portion of tablet, powder 
equivalent to 10 mg of bisoprolol fumarate and transfer into a 100 
ml volumetric flask to this 50 ml solvent (water-acetonitrile 80:20 
v/v) was added and sonicated for 15 min. Solvent (water-
acetonitrile 80:20 v/v) was adjusted up to the mark. The solution 
was filtered using 0.45 μm nylon filter. The amount present in the 
tablet was calculated from plotted calibration graph or utilizing 
regression equation. After setting the chromatographic conditions 
and stabilizing the instrument to obtain a steady baseline, the 
sample solution was loaded in the 10 μl fixed sample loop of the 
injection port. 
Method validation 
Once the chromatographic and the experimental conditions were 
established, the method was validated with respect to specificity, 
linearity, precision, accuracy, robustness, limit of detection (LOD), 
limit of quantitation (LOQ) according to ICH Q2 (R1) guidelines [15, 
16]. 
System suitability parameters 
The chromatographic systems used for analysis must pass system 
suitability before going to start the experiment. At first HPLC system 
is stabilized for forty minutes. Inject blank preparation (single 
injection) and standard preparation (six replicates) and record the 
chromatograms to evaluate the system suitability parameters such 
as tailing factor, theoretical plate count and retention time. The 
parameters such as tailing factor, % RSD and theoretical plates were 
studied. 
Linearity 
A standard stock solution of the bisoprolol fumarate (0.1 mg/ml) 
was prepared with the mobile phase. To study the linearity range of 
drugs, serial dilutions were made from standard stock solution. 
Specificity 
Specificity of an analytical method is its ability to measure accurately 
and specifically the analyte of interest without interference from 
placebo and degradation products. The specificity of the method was 
established by injecting blank, placebo and standard solution in 
triplicate and recording the chromatograms. 
Precision 
The precision of the method was determined by repeatability 
(intraday) and intermediate precision (interday). Repeatability was 
determined by performing six repeated analysis of the same working 
solution of bisoprolol fumarate on the same day, under the same 
experimental conditions. The intermediate precision of the method 
was assessed by carrying out the analysis on different days and also 
by another analyst performing the analysis in the same laboratory 
(between-analysts). 
Accuracy 
The accuracy of a method is defined as the closeness of a measured 
value to the true value. The recovery studies were carried out at 70-
130 % of the target level in the tablet in triplicate each in the 
presence of placebo. 
Robustness 
The robustness was determined by analyzing the same sample 
under a variety of conditions. The factors considered to be: 
variations in the flow rate, detection wavelength and mobile phase 
composition. There were no significant changes in the 
chromatographic pattern when the above modifications were made 
in the experimental conditions, showing thus that the method is 
robust. The % RSD of bisoprolol fumarate should be not more than 
2.0 %. 
LOD and LOQ 
Limit of detection is the lowest concentration in a sample that can be 
detected, but not necessarily quantified under the stated 
experimental conditions. The limit of quantitation is the lowest 
concentration of analyte in a sample which can be quantitatively 
determined with suitable precision and accuracy.  
RESULTS AND DISCUSSION 
Method development and optimization 
The RP-HPLC method was developed to provide specific procedure 
for the rapid quality control analysis of bisoprolol fumarate. To find 
the appropriate HPLC conditions for separation of the examined 
drug, various reversed phase columns, isocratic and gradient mobile 
phase systems were tried, and successfully attempts were 
performed using a RP-C18 chromatographic column Symmetry C18 
column (3.9 mm i.d. X 150 mm, 5 μm) and mobile phase composed of 
acetonitrile: phosphate buffer solution pH 7.0 in the ratio of 25:75 
v/v, at a flow rate of 1.4 ml/min with λmax
 
 at 226 nm. Under the 
described HPLC parameters, the respective compound was clearly 
separated and their corresponding peaks were sharply developed at 
reasonable Rt 2.09 min as shown in (fig. 2). Previous studies show 
more Rt than 2.09 and it means that developed method is more 
rapid [6-13]. The optimum chromatographic conditions and system 
suitability parameters are tabulated in table 1. 
 
Fig. 2: Representative chromatogram of USP bisoprolol fumarate (0.1 mg/ml) using UV detection at 226 nm 
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Table 1: Optimized chromatographic conditions 
Parameter Chromatographic conditions 
Instrument ACQUITY Arc System 
Column Waters Symmetry C18 column (3.9 mm i.d. X 150 mm, 5 μm) 
Mobile phase Acetonitrile: phosphate buffer solution pH 7.0 (25/75, v/v) 
Flow rate 1.4 ml/min 
Detection wavelength UV at 226 nm 
Runtime 10 min 
Column temperature 35 ° C 
Volume of injection loop 10 μl 
Retention time  2.09 min 
*= number of 5 determinations. 
 
System suitability 
According to U. S. Pharmacopeia (USP) states that system suitability 
tests are an integral part of liquid chromatographic methods. They 
are used to verify that the resolution and reproducibility of the 
chromatographic system are adequate for the analysis to be done. 
For HPLC method, it was used to verify that the column efficiency 
(N), selectivity factor (resolution) and reproducibility of the 
chromatographic system. Parameters including resolution (Rs), peak 
symmetry, capacity factor (K'
 
) and selectivity factor (α) were 
calculated, as shown in table 2. All the values are well within the 
limit.
Table 2: Analytical parameters for system suitability test of HPLC 
Parameters Reference Bisoprolol fumarate 
Retention time (min) --------- 2.09 
Resolution (R) R>2 --------- 
Selectivity factor (α) >1  
K' (Column capacity) 0.1-10 acceptable  
Symmetry ______  
Tailing Factor (T) ≤ 2 1.12 
N (column efficiency) Increases with efficiency of the separation 12215 




Calibration curve rеpresenting the rеlation betwеen the concеntrations 
of drugs versus the peak area were constructеd. In triplicatе run from 
which the linear regression equation was calculated. The results of 
chromatographic determination of nine model solutions of bisoprolol 
fumarate are present in table 3. The calibration plot of bisoprolol 
fumarate is presented in (fig. 3) and characteristics of the linear 
dependence of bisoprolol fumarate are listed in table 4.  
The results show that a phenomenal relationship between peak area and 
concentration of the drug in the calibration curve. 
 













R SD N P
------------------------------------------------------------
0,99875 1,01059 9 <0.0001
------------------------------------------------------------































Relative content of bisoprolol, as prepared, X=C (% rel.)
Lineary on ASSAY TEST in "Bisoprolol, tablets 2.5, 5, 10 mg"
 
Fig. 3: The calibration graph of bisoprolol fumarate 
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Table 3: Chromatographic determination of model solutions of bisoprolol fumarate 
Model 
solutions 
Assigned API content, Xi S (%) 
parallel measurements 
i  Average S RSDi i, Found content of API, Y, % i (%) 

















































*Average of triplicate injections 
 
Table 4: Characteristics of the linear dependence of bisoprolol fumarate 
The name of the quantity Value Criteria for the parameters of linear dependence (according to SPU 1.2, p. 85) 
B 0.98433  
sRB 0.01861  
A 1.91924 ≤ 2.56 
sRA 1.89976  
sR  1.01059  
sR R/B 1.02614 ≤ 1.27 
R 0.99875 ≥ 0.997789 
 
The results obtained were procеssed by the least squares method. 
The correlation coefficient of bisoprolol fumarate (rP2P) was noted as 
0.99875 which states that the method was good linear to the 
concentration versus peak area responses. Results indicate high 
sensitivity of the proposed HPLC method.  
Specificity 
Commonly used tablet excipients did not interfere with the proposed 
method. The specificity results are tabulated in table 5. Furthermore, the 
well shaped peaks also indicate the specificity of the method. 
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Table 5: Specificity study 
Name of the solution Retention time (tR) min 
mobile phase No peaks 
placebo No peaks 
bisoprolol fumarate 0.5 mg/ml 2.09 
 
Accuracy and precision 
Intra-day and inter-day precision represented as % RSD values 
lower than 2% clearly assuring that this method was found to be 
fairly precise and reproducible as shown in Tables 6,7. The standard 
addition method was performed at 70 %, 80 %, 90 %, 100 %, 110 %, 
120 %, 130 % levels as illustrated in table 8. % RSD was lower than 
2 % proving the high repeatability of the new method. 
 
Table 6: Results of system precision 
Sample Concentration (μg/ml) Peak area Injection no. RSD, % 
Bisoprolol 0.1 1086.213 1  




*Each value is represented as a mean±SD of 4 observations (n=4), SD: Standard Deviation, RSD: Relative Standard Deviation, #Acceptance 
criteria<2.0. 
 
Table 7: Intra-day and Inter-day precision data of bisoprolol fumarate 
Day Intra-day precision Inter-day precision 
Mean RSD % Mean RSD % 
1 99.82 0.311 100.76 0.364 
2 100.41 0.647 99.27 0.390 
3 100.82 0.336 100.53 0.572 
*Each value is represented as a mean±SD of observations, SD: Standard Deviation, RSD: Relative Standard Deviation, #Acceptance criteria<2.0 
 
Table 8: Evaluation of accuracy of the proposed HPLC method 
Model 
solutions 
The amount of bisoprolol fumarate, % Found,% to predetermined, 
Zi = (Yi/Xi).100% Predetermined quantity, Xi=(mi/mrs Found quantity, Y) 100 % i =(Si/Srs) 100 % 
1 69.93 71.31 101.98 
2 80.92 80.88 99.95 
3 89.91 90.11 100.22 
4 94.91 95.44 100.56 
5 99.90 99.51 99.60 
6 104.90 106.26 101.30 
7 111.89 111.40 99.56 
8 120.88 122.63 101.44 
9 130.87 129.68 99.09 
Average, Z, % 100.41 
Standard deviation, Sz, 0.98  % 
Confidence interval of convergence of results (actual) 
∆ = t (95%,8). Sz = 1.8595. Sz, 
1.82 
% 
Critical value for the convergence of results 
∆ ≤ max∆As
Performed  
 = 2.4% (1.82<2.4) 
Systematic error δ=│Z-100│, % 0.41 
Criterion of significance of systematic error 
δ ≤ max δ% 
Performed  
(0.41<0.77) 
The general conclusion about the technique:  Correct  
*Average of triplicate injections 
 
Regarding accuracy, a known amount of the standard drug was 
added to the fixed amount of preanalyzed sample solution. The 
percentage recovery was calculated by comparing the area before 
and after addition of the standard drug. These data showed that the 
proposed method was both accurate and precise for the 
determination of bisoprolol fumarate in medicines. The high value of 
recoveries obtained for bisoprolol indicates that the proposed 
method was found to be accurate.  
LOD and LOQ 
The LOD and LOQ values are presented in table 9. 
  
Table 9: LOD and LOQ of the proposed HPLC method for bisoprolol fumarate 
Limit of Detection (LOD) 0.4825 μg/ml 
Limit of Quantitation (LOQ) 1.4621 μg/ml 
The developed method found to be high sensitivity with LOD and LOQ of 0.4825 and 1.4621 μg/ml; respectively. The results of LOD and LOQ 
supported the sensitivity of the proposed method. 
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Table 10: Robustness of the proposed HPLC method for bisoprolol fumarate 
Parameter Optimized Used Retention time (min) Remark 


















Mobile phase composition 
(acetonitrile: phosphate buffer solution pH 7.0) (±0.5 %) 









It was evaluated by small deliberate changes in method parameters such as flow rate (±0.2 ml/min), detection wavelength (±5 nm) and mobile 
phase composition (±0.5 %). The % RSD values of robustness which is less than 2 % reveals that the proposed method is robust. The results of 
robustness indicate that even though the small changes in the conditions did not significantly effect on retention time of bisoprolol fumarate. 
  
Table 11: Results of analysis of bisoprolol fumarate 
S. No Formulation Labelled amount, mg/tablet Amount found, mg/tablet Mean % assay±SD % RSD 
1 Bisoprolol tablets 5 4.98 99±1 0.100 
*Average of 5 determinations; SD: standard deviation; RSD: relative standard deviation. 
 
Robustness 
The results of robustness study results are shown in table 10. 
Tablet analysis 
The developed, validated method was successfully applied for the 
determination of bisoprolol fumarate in their tablet dosage form. 
The assay result shows that the amount of the drug was in excellent 
agreement with the labelled value of the formulation as illustrated in 
table 11. 
CONCLUSION 
In conclusion, a rapid, simple, accurate, sensitive and precise HPLC 
method was developed and validated for the estimation of bisoprolol 
fumarate in its tables dosage form. Statistical analysis for the above 
results obviously demonstrates that the method is fit for the 
estimation of bisoprolol fumarate in tablet forms without any 
interference. The proposed method can help research studies, 
quality control and routine analysis with lesser resources available. 
The results of the assay of pharmaceutical formulation of the 
developed method are highly reliable and reproducible and is in 
good agreement with the label claim of the drug.  
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